Papyrus Therapeutics
  • Home
  • About Us
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
  • Our Science
  • News
  • Contact
Select Page
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers – Anthony J, Zanini E, Bartley J R, Gabra H, Recchi C – Published June 29, 2020 in Cancer Gene Therapy

Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers – Anthony J, Zanini E, Bartley J R, Gabra H, Recchi C – Published June 29, 2020 in Cancer Gene Therapy

by jakelange | Jul 8, 2020 | Announcements, Homepage, News

Papyrus Therapeutics Co-Founder Professor Hani Gabra recently contributed to this article about cancer gene therapy. Read the publication here: https://doi.org/10.1038/s41417-020-0187-6

Recent Posts

  • Papyrus Therapeutics Announces Appointment of Daniel Soland as Chief Operating Officer
  • Papyrus Therapeutics Research Presentation at the 34th EORTC-NCI-AACR meeting in Barcelona, Spain, on 27th October
  • Papyrus Therapeutics Announces Formation of Scientific Advisory Board
  • Beth Altman appointed to Board of Directors
  • Marc Beer appointed Chairman of the Board of Directors

Recent Comments

      Copyright 2020 Papyrus Therapeutics | Built By Jacob Lange